PEGylated recombinant human interferon gamma (PHARMACLON)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamePEGylated recombinant human interferon gamma (PHARMACLON)
Drug Alias NameIngaron PRO
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulatorsInterferon gamma receptor stimulants
TargetsInterferon gamma receptor
Therapy Area/IndicationsGranulomatous Disease, ChronicCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaclon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaclon
Active IndicationsN/A
Inactive IndicationsGranulomatous Disease, ChronicCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A